+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

LAMEA Cat Vaccine Market Size, Share & Trends Analysis Report By Component, By Route of Administration (Injectables, Intranasal, and Oral), By Duration of Immunity, By Disease Type, By Type, By Country and Growth Forecast, 2024 - 2031

  • PDF Icon

    Report

  • 136 Pages
  • July 2024
  • Region: Africa, Middle East
  • Marqual IT Solutions Pvt. Ltd (KBV Research)
  • ID: 5988704
Description Jump to:
The Latin America, Middle East and Africa Cat Vaccine Market is projected to witness market growth of 11.7% CAGR during the forecast period (2024-2031).

The Brazil market dominated the LAMEA Cat Vaccine Market by Country in 2023, and is forecast to continue being a dominant market till 2031; thereby, achieving a market value of $54 million by 2031. The Argentina market is capturing a CAGR of 12.6% during (2024 - 2031). Additionally, The UAE market would register a CAGR of 10.9% during (2024 - 2031).



The development of recombinant DNA technology has enabled the production of vaccines that can target specific pathogens with greater precision. This method reduces the risk of adverse reactions and enhances the immune response in cats. As a result, newer vaccines can offer longer-lasting protection against diseases such as feline leukemia virus (FeLV), feline immunodeficiency virus (FIV), and rabies, contributing to cats' overall health and longevity.

Despite the positive trends, the market also faces several challenges. One of the most significant barriers is the high cost of vaccines, which can deter pet owners, especially those with multiple cats or limited financial resources. Even with the availability of pet insurance, the upfront costs associated with comprehensive vaccination schedules can be prohibitive for some. This financial burden can lower vaccination rates, leaving cats vulnerable to preventable diseases.

The South African Veterinary Association (SAVA) has actively promoted the importance of regular vaccinations through public health initiatives and educational campaigns. The Department of Agriculture, Forestry, and Fisheries (DAFF) supports these efforts by ensuring that veterinary services are accessible and affordable. The demand for cat vaccines has been driven by enhanced public awareness and the increasing disposable income of pet owners, who are more inclined to invest in preventive healthcare for their animals. Thus, the LAMEA cat vaccine market has growth potential fueled by rising pet ownership and increasing awareness of animal welfare.

List of Key Companies Profiled

  • Zoetis, Inc.
  • Elanco Animal Health, Inc.
  • Merck & Co., Inc.
  • Boehringer Ingelheim International GmbH
  • Covetrus, Inc. (Clayton, Dubilier & Rice, LLC)
  • Virbac
  • Heska Corporation (Antech Diagnostics, Inc)
  • Ceva Sante Animale
  • Bioveta, a.s.

Market Report Segmentation

By Component
  • Combined Vaccines
  • Mono Vaccines
By Route of Administration
  • Injectables
  • Intranasal
  • Oral
By Duration of Immunity
  • 1 Year
  • 3 Year
  • Others
By Disease Type
  • Feline Respiratory Diseases
  • Feline Rabies
  • Feline Panleukopenia (Feline Distemper)
  • Feline Leukemia
  • Others
By Type
  • Modified/Attenuated Live
  • Inactivated (Killed)
  • Others
By Country
  • Brazil
  • Argentina
  • UAE
  • Saudi Arabia
  • South Africa
  • Nigeria
  • Rest of LAMEA

Table of Contents

Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 LAMEA Cat Vaccine Market, by Component
1.4.2 LAMEA Cat Vaccine Market, by Route of Administration
1.4.3 LAMEA Cat Vaccine Market, by Duration of Immunity
1.4.4 LAMEA Cat Vaccine Market, by Disease Type
1.4.5 LAMEA Cat Vaccine Market, by Type
1.4.6 LAMEA Cat Vaccine Market, by Country
1.5 Methodology for the research
Chapter 2. Market at a Glance
2.1 Key Highlights
Chapter 3. Market Overview
3.1 Introduction
3.1.1 Overview
3.1.1.1 Market Composition and Scenario
3.2 Key Factors Impacting the Market
3.2.1 Market Drivers
3.2.2 Market Restraints
3.2.3 Market Opportunities
3.2.4 Market Challenges
3.3 Porter Five Forces Analysis
Chapter 4. Strategies Deployed in Cat Vaccine Market
Chapter 5. LAMEA Cat Vaccine Market by Component
5.1 LAMEA Combined Vaccines Market by Country
5.2 LAMEA Mono Vaccines Market by Country
Chapter 6. LAMEA Cat Vaccine Market by Route of Administration
6.1 LAMEA Injectables Market by Country
6.2 LAMEA Intranasal Market by Country
6.3 LAMEA Oral Market by Country
Chapter 7. LAMEA Cat Vaccine Market by Duration of Immunity
7.1 LAMEA 1 Year Market by Country
7.2 LAMEA 3 Year Market by Country
7.3 LAMEA Others Market by Country
Chapter 8. LAMEA Cat Vaccine Market by Disease Type
8.1 LAMEA Feline Respiratory Diseases Market by Country
8.2 LAMEA Feline Rabies Market by Country
8.3 LAMEA Feline Panleukopenia (Feline Distemper) Market by Country
8.4 LAMEA Feline Leukemia Market by Country
8.5 LAMEA Others Market by Country
Chapter 9. LAMEA Cat Vaccine Market by Type
9.1 LAMEA Modified/Attenuated Live Market by Country
9.2 LAMEA Inactivated (Killed) Market by Country
9.3 LAMEA Others Market by Country
Chapter 10. LAMEA Cat Vaccine Market by Country
10.1 Brazil Cat Vaccine Market
10.1.1 Brazil Cat Vaccine Market by Component
10.1.2 Brazil Cat Vaccine Market by Route of Administration
10.1.3 Brazil Cat Vaccine Market by Duration of Immunity
10.1.4 Brazil Cat Vaccine Market by Disease Type
10.1.5 Brazil Cat Vaccine Market by Type
10.2 Argentina Cat Vaccine Market
10.2.1 Argentina Cat Vaccine Market by Component
10.2.2 Argentina Cat Vaccine Market by Route of Administration
10.2.3 Argentina Cat Vaccine Market by Duration of Immunity
10.2.4 Argentina Cat Vaccine Market by Disease Type
10.2.5 Argentina Cat Vaccine Market by Type
10.3 UAE Cat Vaccine Market
10.3.1 UAE Cat Vaccine Market by Component
10.3.2 UAE Cat Vaccine Market by Route of Administration
10.3.3 UAE Cat Vaccine Market by Duration of Immunity
10.3.4 UAE Cat Vaccine Market by Disease Type
10.3.5 UAE Cat Vaccine Market by Type
10.4 Saudi Arabia Cat Vaccine Market
10.4.1 Saudi Arabia Cat Vaccine Market by Component
10.4.2 Saudi Arabia Cat Vaccine Market by Route of Administration
10.4.3 Saudi Arabia Cat Vaccine Market by Duration of Immunity
10.4.4 Saudi Arabia Cat Vaccine Market by Disease Type
10.4.5 Saudi Arabia Cat Vaccine Market by Type
10.5 South Africa Cat Vaccine Market
10.5.1 South Africa Cat Vaccine Market by Component
10.5.2 South Africa Cat Vaccine Market by Route of Administration
10.5.3 South Africa Cat Vaccine Market by Duration of Immunity
10.5.4 South Africa Cat Vaccine Market by Disease Type
10.5.5 South Africa Cat Vaccine Market by Type
10.6 Nigeria Cat Vaccine Market
10.6.1 Nigeria Cat Vaccine Market by Component
10.6.2 Nigeria Cat Vaccine Market by Route of Administration
10.6.3 Nigeria Cat Vaccine Market by Duration of Immunity
10.6.4 Nigeria Cat Vaccine Market by Disease Type
10.6.5 Nigeria Cat Vaccine Market by Type
10.7 Rest of LAMEA Cat Vaccine Market
10.7.1 Rest of LAMEA Cat Vaccine Market by Component
10.7.2 Rest of LAMEA Cat Vaccine Market by Route of Administration
10.7.3 Rest of LAMEA Cat Vaccine Market by Duration of Immunity
10.7.4 Rest of LAMEA Cat Vaccine Market by Disease Type
10.7.5 Rest of LAMEA Cat Vaccine Market by Type
Chapter 11. Company Profiles
11.1 Zoetis, Inc.
11.1.1 Company Overview
11.1.2 Financial Analysis
11.1.3 Regional Analysis
11.1.4 Research & Development Expenses
11.1.5 Recent strategies and developments:
11.1.5.1 Partnerships, Collaborations, and Agreements:
11.1.5.2 Product Launches and Product Expansions:
11.1.5.3 Acquisition and Mergers:
11.1.6 SWOT Analysis
11.2 Elanco Animal Health, Inc.
11.2.1 Company Overview
11.2.2 Financial Analysis
11.2.3 Regional Analysis
11.2.4 Research & Development Expenses
11.2.5 SWOT Analysis
11.3 Merck & Co., Inc.
11.3.1 Company Overview
11.3.2 Financial Analysis
11.3.3 Segmental and Regional Analysis
11.3.4 Research & Development Expenses
11.3.5 SWOT Analysis
11.4 Boehringer Ingelheim International GmbH
11.4.1 Company Overview
11.4.2 Financial Analysis
11.4.3 Regional & Segmental Analysis
11.4.4 Research & Development Expenses
11.4.5 Recent strategies and developments:
11.4.5.1 Trials and Approvals:
11.4.6 SWOT Analysis
11.5 Covetrus, Inc. (Clayton, Dubilier & Rice, LLC)
11.5.1 Company Overview
11.5.2 SWOT Analysis
11.6 Virbac
11.6.1 Company Overview
11.6.2 Financial Analysis
11.6.3 Regional Analysis
11.6.4 Recent strategies and developments:
11.6.4.1 Acquisition and Mergers:
11.6.5 SWOT Analysis
11.7 Heska Corporation (Antech Diagnostics, Inc)
11.7.1 Company Overview
11.7.2 SWOT Analysis
11.8 Ceva Sante Animale
11.8.1 Company Overview
11.8.2 SWOT Analysis
11.9 Bioveta, a.s.
11.9.1 Company Overview

Companies Mentioned

  • Zoetis, Inc.
  • Elanco Animal Health, Inc.
  • Merck & Co., Inc.
  • Boehringer Ingelheim International GmbH
  • Covetrus, Inc. (Clayton, Dubilier & Rice, LLC)
  • Virbac
  • Heska Corporation (Antech Diagnostics, Inc)
  • Ceva Sante Animale
  • Bioveta, a.s.

Methodology

Loading
LOADING...

Related Topics

Related Reports

Global Cat Vaccine Market Size, Share & Trends Analysis Report By Component, By Route of Administration (Injectables, Intranasal, and Oral), By Duration of Immunity, By Disease Type, By Type, By Regional Outlook and Forecast, 2024 - 2031 - Product Image

Global Cat Vaccine Market Size, Share & Trends Analysis Report By Component, By Route of Administration (Injectables, Intranasal, and Oral), By Duration of Immunity, By Disease Type, By Type, By Regional Outlook and Forecast, 2024 - 2031

  • Report
  • 302 Pages
  • Global
From
Global Cat Vaccine Market Size, Share & Trends Analysis Report by Vaccine Type (Inactivated), Disease Type, Route of Administration, Duration of Immunity, Component, Region, and Segment Forecasts, 2024-2030 - Product Image

Global Cat Vaccine Market Size, Share & Trends Analysis Report by Vaccine Type (Inactivated), Disease Type, Route of Administration, Duration of Immunity, Component, Region, and Segment Forecasts, 2024-2030

  • Report
  • 100 Pages
  • Global
From
Europe Cat Vaccine Market Size, Share & Trends Analysis Report By Component, By Route of Administration (Injectables, Intranasal, and Oral), By Duration of Immunity, By Disease Type, By Type, By Country and Growth Forecast, 2024 - 2031 - Product Image

Europe Cat Vaccine Market Size, Share & Trends Analysis Report By Component, By Route of Administration (Injectables, Intranasal, and Oral), By Duration of Immunity, By Disease Type, By Type, By Country and Growth Forecast, 2024 - 2031

  • Report
  • 136 Pages
  • Europe
From
Principles and Practices of Canine and Feline Clinical Parasitic Diseases. Edition No. 1 - Product Image

Principles and Practices of Canine and Feline Clinical Parasitic Diseases. Edition No. 1

  • Book
  • 304 Pages
Companion Animal Vaccine - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029 - Product Image

Companion Animal Vaccine - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029

  • Report
  • 109 Pages
  • Global
From

About the Market

The Feline Vaccine market is a segment of the Animal Pharmaceuticals industry that focuses on the development and distribution of vaccines for cats. Vaccines are used to protect cats from a variety of diseases, including feline leukemia, rabies, and feline infectious peritonitis. Vaccines are typically administered by veterinarians, and may be given as a single dose or as a series of doses. Vaccines are also available in a variety of forms, including injectable, oral, and intranasal. The Feline Vaccine market is highly competitive, with a number of companies offering a wide range of products. Companies in the market include Merck Animal Health, Boehringer Ingelheim, Elanco, Zoetis, and Ceva Animal Health. These companies offer a variety of vaccines, including those for feline leukemia, rabies, and feline infectious peritonitis. Show Less Read more

Copyright © 2002-2024 Research and Markets. All Rights Reserved.